In the project "Digital Business Processes in Medicine" (German: Digitale Geschäftsprozesse der Medizin, Digemed), the potential of digital biopsy using a high-performance Zeiss CONVIVO endomicroscope is being investigated and assessed using the example of surgical resection of brain tumours. The project, which is coordinated by Prof. Dr. med. Walter Swoboda at HNU’s DigiHealth Institute, also involves the Department of Neuropathology of the Clinical Centre of the Technical University of Munich (TUM), the company Carl Zeiss Meditec AG, and the company ClarCert GmbH. The project is funded by the Bavarian State Ministry of Sciences and Arts for three years (January 2019 to December 2021).
An additional aim of the Digemed project is to ensure that the new method can also be used in other areas of digital medicine in the future, while complying with the requirements of eHealth functionality, data protection and telematics infrastructure and being adaptable to various clinical processes. The project also promotes and evaluates cooperation between universities, industry, and hospitals in the field of clinical process optimisation using digital business models.
The Digemed project coordinated at the Institute DigiHealth thus represents innovation and progress in the field of "Digital Transformation" (topic area B.TOP), one of the nine main topics of the Future Code Bayern platform, where scientists from Bavaria's universities of applied sciences provide information on current developments. It also supports one of HNU's central research fields, digitization in medicine and care.
Link: Future Code Bayern
![[Translate to English:] (opens enlarged image)](/fileadmin/_processed_/f/3/csm_Endomikroskop_Zellen_Digemed_NeuropathologieTUM_768659f22a.jpg "[Translate to English:] (opens enlarged image)")
Professor Dr. Walter Swoboda
Research Professor at the Faculty of Health Management
Head of the DigiHealth Institute
Chairman of the Joint Ethics Committee of the Bavarian Universities (GEHBa)
